Abbott Laboratories logo

Abbott Laboratories

ABT | NYSE
Chart Builder DCF Calculator
$107.45
-$1.07 (-0.99%)
At close: Nov 16, 2026, 4:02 PM ET
$106.76
-$0.69 (-0.64%)
After-hours: Nov 16, 2026, 7:18 PM ET
-0.99%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
47.7
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #337/1021 (Top 33%)

Why Price Moved

14 days ago
+3.73%

Shares are trading higher after Abbott reported fa...

Key Statistics

Market Data

Market Cap $186.1B
1D Range
107.28 110.44
52W Range
82.56 130.03

Valuation (TTM)

PE 39.80
PB 3.64
EV/EBITDA 21.95

Valuation (NTM)

Forward PE 19.66
Forward PEG 5.65
Price Target $120.00
Loading financial charts...

Profile

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of h...

Sector Healthcare
Employees 115,000
IPO Date Mar 17, 1980
Fiscal Year January - December

Latest News

Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026

16 hours ago · zacks.com

Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026
Is ABT Overvalued? DCF Says Worth $76

17 hours ago · gurufocus.com

Is ABT Overvalued? DCF Says Worth $76
Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings?

3 days ago · zacks.com

Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings?
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

5 days ago · zacks.com

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Can UltiSynq Lead Boost Abbott's Cardiac Rhythm Management Business?

5 days ago · zacks.com

Can UltiSynq Lead Boost Abbott's Cardiac Rhythm Management Business?
3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years

10 days ago · 247wallst.com

3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 Years
These 12 stocks are good bets to beat the 10-year Treasury over the next decade

13 days ago · marketwatch.com

These 12 stocks are good bets to beat the 10-year Treasury over the next decade
Abbott Touts Favorable Outcomes In Cardiovascular Device Trials

15 days ago · benzinga.com

Abbott Touts Favorable Outcomes In Cardiovascular Device Trials
Late-breaking one-year data show Abbott's next-generation Amulet 360™ device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke

15 days ago · prnewswire.com

Late-breaking one-year data show Abbott's next-generation Amulet 360™ device continues to demonstrate high rates of left atrial appendage closure and low incidence of stroke
Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

15 days ago · gurufocus.com

Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy System

Earnings

Latest Earnings
Oct 21, 2026
EPS
$1.42
Beat 0.00%
REV
$13.01B
Beat +0.18%
Next Earnings
Jan 28, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
21
Consensus
Buy
Price Target
$120.00
Upside
+11.68%
Buy (20)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.